Sage Therapeutics Inc (SAGE) — Cash Flow Reinvestment Rate
Sage Therapeutics Inc (SAGE) has a Cash Flow Reinvestment Rate of 0.05x as of December 2020, reinvesting $45.52 Million (capex $1.00K plus investments $45.52 Million) from operating cash flow of $1.01 Billion. Check Sage Therapeutics Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sage Therapeutics Inc Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Sage Therapeutics Inc across 1 annual periods. Explore Sage Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Sage Therapeutics Inc (2020–2020)
Year-by-year capital reinvestment analysis for Sage Therapeutics Inc. For live market cap and broader valuation context, see SAGE stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.67x | $443.37 Million | $664.28 Million | $345.00K | — |